Brendan Digan
Stock Analyst at Citi
(2.18)
# 3,209
Out of 4,974 analysts
7
Total ratings
66.7%
Success rate
17.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Brendan Digan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Reiterated: Buy | $315 → $365 | $350.78 | +4.05% | 3 | Aug 14, 2026 | |
| QGEN Qiagen | Reiterated: Hold | $45 | $42.48 | +5.93% | 1 | Aug 10, 2026 | |
| SHC Sotera Health Company | Reiterated: Buy | $25 | $18.98 | +31.72% | 1 | Aug 7, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | $50 | $74.39 | -32.79% | 1 | Aug 7, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Hold | $180 | $172.45 | +4.38% | 1 | Jul 31, 2026 |
Natera
Aug 14, 2026
Reiterated: Buy
Price Target: $315 → $365
Current: $350.78
Upside: +4.05%
Qiagen
Aug 10, 2026
Reiterated: Hold
Price Target: $45
Current: $42.48
Upside: +5.93%
Sotera Health Company
Aug 7, 2026
Reiterated: Buy
Price Target: $25
Current: $18.98
Upside: +31.72%
10x Genomics
Aug 7, 2026
Reiterated: Hold
Price Target: $50
Current: $74.39
Upside: -32.79%
ICON Public Limited Company
Jul 31, 2026
Reiterated: Hold
Price Target: $180
Current: $172.45
Upside: +4.38%